Galloway D R, McCabe R P, Pellegrino M A, Ferrone S, Reisfeld R A
J Immunol. 1981 Jan;126(1):62-6.
Xenoantisera to human melanoma cells and to partially purified melanoma-associated antigens were coupled to protein A-bearing Staphylococcus Aureus or protein A-Sepharose and used as immunoadsorbents for the indirect immunoprecipitation of intrinsically radiolabeled proteins released into culture medium from various cultured human tumor and nontumor cell lines. These radiolabeled immunoprecipitates when analyzed by SDS-PAGE revealed highly reproducible molecular profiles of proteins and glycoproteins released by various cultured tumor lines and control cells into their spent culture media. A comparison of molecular profiles together with data indicating the binding specificity of known xenoantisera produced against human melanoma cells or their extracts led to the discovery of 2 macromolecules that are associated with human melanoma cells; a glycoprotein with a subunit m.w. of 240,000 (240K) and a single-chain glycoprotein of 94,000 (94K) m.w. also found in association with human carcinoma cells are described in this report.
将针对人黑色素瘤细胞和部分纯化的黑色素瘤相关抗原的异种抗血清与携带蛋白A的金黄色葡萄球菌或蛋白A-琼脂糖偶联,并用作免疫吸附剂,用于间接免疫沉淀从各种培养的人肿瘤和非肿瘤细胞系释放到培养基中的内源性放射性标记蛋白。当通过SDS-PAGE分析这些放射性标记的免疫沉淀物时,揭示了各种培养的肿瘤系和对照细胞释放到其用过的培养基中的蛋白质和糖蛋白的高度可重复的分子图谱。分子图谱的比较以及表明针对人黑色素瘤细胞或其提取物产生的已知异种抗血清的结合特异性的数据,导致发现了2种与人黑色素瘤细胞相关的大分子;本报告描述了一种亚基分子量为240,000(240K)的糖蛋白和一种分子量为94,000(94K)的单链糖蛋白,后者也与人癌细胞相关。